Yonghoe and Jaehyun won presentation awards at the KSBM Fall Meeting.

Our lab members received prestigious awards at the Fall Meeting of the Korean Society for Biomaterials (KSBM). Yonghoe Koo won the Best Oral Presentation Award for his research titled “Wavelength-Tunable Photonic Crystal Sensors for Dynamic Assessment of Skin Healing”. Jaehyun Park received the Best Poster Presentation Award for his work titled “CRIP2-targeted gene silencing via […]

Read More »

Collaborative study on multiplexed CRISPR/Cas9 cancer therapy published in Cancer Research.

Our collaborative research on targeted cancer therapeutics using multiplexed CRISPR/Cas9 has been published in Cancer Research. This study was successfully achieved through a joint effort with the research groups of Prof. Seung Woo Cho, Prof. Tae-Eun Park, Prof. Taejoon Kwon, and Prof. Kyungjae Myung. The technology enhances precise therapeutic efficacy by specifically targeting mutated DNA […]

Read More »

Dongyong joined the lab as a new graduate student

Dongyong Lee has officially joined our laboratory as an MS/Ph.D. integrated program student. As an undergraduate in Biomedical Engineering at UNIST, Dongyong first started his research journey in our lab as an intern back in 2020. During his undergraduate years, he gained diverse and valuable experience, including tech transfer and founding a startup, before advancing […]

Read More »

Our UIRP student team won the Best Poster Award at the KBCS Fall Meeting.

A combined research team consisting of graduate student Seohyun Kim and undergraduate students Kangmin Kim, Yubin Park, and Yeonji Lee won the Best Poster Award at the Fall Meeting of the Korean BioChip Society. Their presentation was titled “Optimized Lipid Nanoparticle-based CRISPR-Cas9 Delivery for Enhanced Gene Therapy in Cancer.” This outstanding achievement is the culmination […]

Read More »

Paper published in Chemical Engineering Journal

Our collaboration work on long-lived phosphorescence of silica nanoparticles with Profs. Woosung Kwon (Sookmyung Women’s University) and Kyeonghak Kim (Hanyang University) has been published in Chemical Engineering Journal. This work reports a use of defect-engineered silica nanoparticle that presents room-temperature phosphorescence with extended lifetime up to a few milliseconds-scale. Such a long lifetime allows tissue […]

Read More »

Paper published in Nano Today

Our collaborative work on biodegradable nanoparticles and controlled ferroptosis has been published in Nano Today. This work reports spatiotemporal tracking of intracellular nanoparticles using multimodal imaging systems including super-resolution microscopy and fluorescence correlation spectroscopy to reveal the ultimate fate of single nanoparticles upon autophagic clearance. Moreover, this study showed controlled ferroptosis upon triggered reduction of […]

Read More »

Jisu joined our group for graduate study

Jisu Im joined our group for graduate study in biomedical engineering as a master candidate. Jisu majored biotechnology in undergraduate at the Catholic University of Korea, and worked in our group as an undergraduate internship researcher (2023.07-08). She will be working on the nanoparticled-based CRISPR/Cas9 delivery systems.

Read More »

Paper published in Journal of Nanobiotechnology

A collaborative work with Prof. Hee Ho Park’s lab at Hanyang University for enhanced tissue regeneration using human serum albumin-based protein nanoparticles has been published in Journal of Nanobiotechnology:https://jnanobiotechnology.biomedcentral.com/articles/10.1186/s12951-023-02053-4 In this work, we report significantly improved would healing performance by using human serum albumin-mediated nanoparticle formulation with soluble bFGF. A systematic investigation both in vitro […]

Read More »

Younjin joined our group for graduate study

Younjin Jeong joined our group as a MS/PhD student in biomedical engineering. She majored biomedical engineering in undergraduate at UNIST, and worked with our group for 2 years as an undergraduate researcher. She will be working on development of anti-cancer technology using nanoparticles and CRISPR/Cas9. Welcome aborad!

Read More »